ClinicalTrials.gg
Sign In

Fetal Growth Retardation clinical trials

The registry lists 262 studies for Fetal Growth Retardation across more than 10 countries. 69 are recruiting or about to start. 163 of them are mainly about Fetal Growth Retardation (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Fetal Growth Retardation studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
113
Status unknown
52
Recruiting
48
Not yet recruiting
16
Terminated
13
Active, not recruiting
9

Phase

Phase 3
25
Phase 2
11
Phase 4
9
Early Phase 1
2
Phase 1
2

Where

United States
43
France
29
Egypt
22
Spain
18
Turkey
18
Canada
12

Who runs them

Assiut University (10) · Assistance Publique - Hôpitaux de Paris (6) · University of Aarhus (5) · Ain Shams University (5) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (4) · Ain Shams Maternity Hospital (4) · CHU de Quebec-Universite Laval (4) · The University of Texas Health Science Center, Houston (3)

What is being tested here

Drugs under test in Fetal Growth Retardation studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Enoxaparin235
Melatonin213
Aspirin148
Lactoferrin101
Pravastatin101
Contrast agent BR1111
Sulfur Hexafluoride111
Citrulline101
Sildenafil068
Human Growth Hormone033

Coming up

4phase 3 studies under way
21studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 48 Fetal Growth Retardation studies recruiting now, 24 (50%) set no upper age limit and 21 (44%) stop at 75 or younger. 16 (33%) take children under 18. 37 (77%) are for women only and 0 (0%) for men only; 24 (50%) take healthy volunteers.

Recruiting studies that take each age, of 48
AgeWomenMen
107 (15%)5 (10%)
1842 (88%)7 (15%)
3042 (88%)5 (10%)
4041 (85%)5 (10%)
5033 (69%)5 (10%)
6528 (58%)4 (8%)
7527 (56%)4 (8%)
8527 (56%)4 (8%)

Across all 262 studies, recruiting or not: 58% stop at 75 or younger and 58% at 65; 31% take children; 82% are for women only and 0% for men only; 48% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Fetal Growth Retardation studies take

Of 73 observational studies under Fetal Growth Retardation, half reached primary completion within 52 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase35 mo18–52 · 40 studies—35 mo18–52 · 39 studies
Observational52 mo24–170 · 73 studies—52 mo24–170 · 72 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 262. Browse all 262 → or search them.